메뉴 건너뛰기
Gastrointestinal Cancer Research
Volumn 3, Issue 5, 2009, Pages 206-207
Challenges of incorporating pharmacogenomics into clinical practice
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; FLUOROURACIL; GLUCURONOSYLTRANSFERASE 1A1; IRINOTECAN;
EID: 77953412963     PISSN: 19347820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial
Times cited : (7)
References (15)
  • 1
    • 77953440835 scopus 로고    scopus 로고
    • The increasing role of pharmacogenetics in the treatment of gastrointestinal cancers
    • Yalçin Ş: The increasing role of pharmacogenetics in the treatment of gastrointestinal cancers. Gastrointest Cancer Res 3:197-203, 2009
    • (2009) Gastrointest Cancer Res , vol.3 , pp. 197-203
    • Yalçin, S.1
  • 2
    • 0037421590 scopus 로고    scopus 로고
    • Pharmacogenomics-drug disposition, drug targets, and side effects
    • Evans WE, McLeod HL. Pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med 348:538-549, 2003
    • (2003) N Engl J Med , vol.348 , pp. 538-549
    • Evans, W.E.1    McLeod, H.L.2
  • 3
    • 67650642313 scopus 로고    scopus 로고
    • Clinically available pharmacogenomics tests
    • Flockhart D, Skaar T, Berlin D, et al: Clinically available pharmacogenomics tests. Clin Pharmacol Ther 86:109-113, 2009
    • (2009) Clin Pharmacol Ther , vol.86 , pp. 109-113
    • Flockhart, D.1    Skaar, T.2    Berlin, D.3
  • 4
    • 3042720559 scopus 로고    scopus 로고
    • Application of pharmacogenomics in the individualization of chemotherapy for gastrointestinal malignancies
    • McLeod HL, King CR, Marsh S: Application of pharmacogenomics in the individualization of chemotherapy for gastrointestinal malignancies. Clin Colorectal Cancer 4(suppl 1):S43-S47, 2004
    • (2004) Clin Colorectal Cancer , vol.4 , Issue.SUPPL. 1
    • McLeod, H.L.1    King, C.R.2    Marsh, S.3
  • 5
    • 29244461993 scopus 로고    scopus 로고
    • Pharmacogenetics of colorectal cancer
    • Marsh S: Pharmacogenetics of colorectal cancer. Expert Opin Pharmacother 6:2607-2616, 2005
    • (2005) Expert Opin Pharmacother , vol.6 , pp. 2607-2616
    • Marsh, S.1
  • 6
    • 6344231838 scopus 로고    scopus 로고
    • Pharmacogenetics of irinotecan toxicity
    • Marsh S, McLeod HL: Pharmacogenetics of irinotecan toxicity. Pharmacogenomics 5:835-843,2004
    • (2004) Pharmacogenomics , vol.5 , pp. 835-843
    • Marsh, S.1    McLeod, H.L.2
  • 7
    • 41549141441 scopus 로고    scopus 로고
    • Irinotecan pharmacogenetics: Influence of pharmacodynamic genes
    • Hoskins, JM, Marcuello E, Altes A: Irinotecan pharmacogenetics: influence of pharmacodynamic genes. Clin Cancer Res 14:1788-1796,2008
    • (2008) Clin Cancer Res , vol.14 , pp. 1788-1796
    • Hoskins, J.M.1    Marcuello, E.2    Altes, A.3
  • 8
    • 69249091037 scopus 로고    scopus 로고
    • Direct-to-consumer genetic testing: Two sides of the coin
    • Farkas DH, Holland CA: Direct-to-consumer genetic testing: two sides of the coin. J Mol Diagn 11:263-265, 2009
    • (2009) J Mol Diagn , vol.11 , pp. 263-265
    • Farkas, D.H.1    Holland, C.A.2
  • 9
    • 67649171897 scopus 로고    scopus 로고
    • Personal genomics services: Whose genomes?
    • Gurwitz D, Bregman-Eschet Y: Personal genomics services: whose genomes? Eur J Hum Genet 17:883-889, 2009
    • (2009) Eur J Hum Genet , vol.17 , pp. 883-889
    • Gurwitz, D.1    Bregman-Eschet, Y.2
  • 10
    • 67649217506 scopus 로고    scopus 로고
    • Genetic horoscopes: Is it all in the genes? Points for regulatory control of direct-to-consumer genetic testing
    • Patch C, Sequeiros J, Cornel MC: Genetic horoscopes: is it all in the genes? Points for regulatory control of direct-to-consumer genetic testing. Eur J Hum Genet 17:857-859, 2009
    • (2009) Eur J Hum Genet , vol.17 , pp. 857-859
    • Patch, C.1    Sequeiros, J.2    Cornel, M.C.3
  • 11
    • 34548598459 scopus 로고    scopus 로고
    • UGT1A1*28 and irinotecan-induced neutropenia: Does dose matter?
    • Hoskins JM, Goldberg RM, Qu P, et al: UGT1A1*28 and irinotecan-induced neutropenia: does dose matter? J Natl Cancer Inst 99:1290-1295, 2007
    • (2007) J Natl Cancer Inst , vol.99 , pp. 1290-1295
    • Hoskins, J.M.1    Goldberg, R.M.2    Qu, P.3
  • 12
    • 64749093541 scopus 로고    scopus 로고
    • Use of electronic health records in U.S. hospitals
    • Jha AK, DesRoches CM, Campbell EG, et al: Use of electronic health records in U.S. hospitals. N Engl J Med 360:1628-1638, 2009
    • (2009) N Engl J Med , vol.360 , pp. 1628-1638
    • Jha, A.K.1    DesRoches, C.M.2    Campbell, E.G.3
  • 13
    • 77953367119 scopus 로고    scopus 로고
    • Behind the PGx challenge: Biofx
    • July/August:19-20
    • van Rooij T: Behind the PGx challenge: Biofx. Genome Technology July/August:19-20, 2007
    • (2007) Genome Technology
    • van Rooij, T.1
  • 14
    • 1542499495 scopus 로고    scopus 로고
    • Drug pathways: Moving beyond single gene pharmacogenetics
    • McLeod HL: Drug pathways: moving beyond single gene pharmacogenetics. Pharmacogenomics 5:139-141, 2004
    • (2004) Pharmacogenomics , vol.5 , pp. 139-141
    • McLeod, H.L.1
  • 15
    • 23044433245 scopus 로고    scopus 로고
    • Pharmacogenetics goes 3D
    • McLeod HL, Marsh S: Pharmacogenetics goes 3D. Nat Genet 37:794-795, 2005
    • (2005) Nat Genet , vol.37 , pp. 794-795
    • McLeod, H.L.1    Marsh, S.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.